8-K 1 d8k.htm FORM 8-K Form 8-K

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) April 1, 2005

 


 

IMPAC Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

 


 

Delaware   000-50082   94-3109238

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

100 West Evelyn Avenue, Mountain View, CA   94041
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (650) 623-8800

 

 

(Former name or former address if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))

 



Item 8.01. Other Events.

 

On April 1, 2005, IMPAC Medical Systems, Inc. (the “Company”) issued a press release announcing the expiration of the waiting period of its premerger notification previously filed with the Department of Justice and the Federal Trade Commission. A copy of the press release is attached as Exhibit 99.1.

 

Item 9.01. Financial Statements and Exhibits.

 

  (c) Exhibits.

 

99.1    IMPAC Medical Systems, Inc. Press Release dated April 1, 2005.

 

 

2


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

IMPAC MEDICAL SYSTEMS, INC.
By:  

/s/ Kendra A. Borrego


   

Kendra A. Borrego

Chief Financial Officer

 

Date: April 1, 2005

 

3


EXHIBIT INDEX

 

Exhibit No.

 

Description


99.1   IMPAC Medical Systems, Inc. Press Release dated April 1, 2005.